Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

NCT05568459

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • University of Colorado Hemophilia and Thrombosis Center Aurora, Colorado, United States
  • Yale HTC New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Gainesville, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

FT819 in Subjects With B-cell Malignancies

NCT04629729

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Arizona Phoenix, Arizona, United States
  • UC Davis Davis, California, United States
  • Scripps Green Hospital La Jolla, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence

NCT04797000

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • Novartis Investigative Site Narita, Chiba, Japan
  • Novartis Investigative Site Kurume, Fukuoka, Japan
  • Novartis Investigative Site Ohtake, Hiroshima, Japan
  • Novartis Investigative Site Nishinomiya, Hyōgo, Japan
View all 20 locations
View Trial Details
Active, Not Recruiting

Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test

NCT04635384

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations
  • University of California Irvine Brisbane, California, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
View Trial Details
Active, Not Recruiting

A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

NCT05257083

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Arkansas Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health Moores Cancer Center San Diego, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL

NCT05478512

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Ematologia AOU Careggi Florence, Italy
  • Ematologia IRST D.Amadori Meldola, Italy
  • Ematologia AO di Perugia Perugia, Italy
  • Ematologia Ospedale S.M. delle Croci Ravenna, Italy
View Trial Details

Related conditions